École Supérieure de Biotechnologie de Strasbourg
In research, École Supérieure de Biotechnologie de Strasbourg stands highest in Life Sciences (#6,572 of 14,347 worldwide), over all time.
- World rank, all time
- #14,126 of 42,892
- Rank in France
- #926 of 2,321
- Research works
- 217 ▼ 10% vs 2013–17
- Citations
- 15k 68.8 per fractional work
- Top-10% rate
- 10.1% record average 16.5%
- Open access
- 44% world 28%
What is École Supérieure de Biotechnologie de Strasbourg known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #6,572 of 14,347 | 28.4% | 144 |
Each strip is that field’s whole ranked pool, with the notch where École Supérieure de Biotechnologie de Strasbourg sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.4×. Every wedge is a field page.
Which keywords describe research at École Supérieure de Biotechnologie de Strasbourg?
By fractional works in all years, weighted toward what it does more of than the world: Homologous Recombination, Cancer Therapy, Signal Transduction, Cancer, Chromatin, DNA Damage, Glycosylation and Genomic Instability.
- Genomics
- Bacterial Physiology
- Receptors
- Fc Receptors
- Depression
- Membrane Proteins
- Anxiety
- Gene Regulation
- Arrestin
- Molecular Mechanisms
- Pharmacology
- Therapeutic Antibodies
- PARP Inhibitors
- Synthetic Lethality
- Drug Discovery
- ATM and ATR Kinases
- Genomic Instability
- DNA Damage
- Signal Transduction
- Cancer Therapy
- Homologous Recombination
- Cancer
- Chromatin
- Cell Death
- Glycosylation
- Repair
- DNA Repair
- BRCA Mutation
- Monoclonal Antibodies
- Cell Signaling
- Crystal Structure
- Antibiotic Resistance
- G-Protein-Coupled Receptors
- Stress
- Immune Modulation
- Neuropeptides
- Antibody Engineering
- Opioid
- RNA Regulation
- Cellular Homeostasis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Homologous Recombination22▲ 149×2 topics
- Cancer Therapy22▲ 16×14 topics
- Cancer18▲ 6.1×28 topics
- Signal Transduction17▲ 32×5 topics
- Chromatin14▲ 69×2 topics
- DNA Damage13▲ 46×2 topics
- Cell Death12▲ 27×5 topics
- Genomic Instability12▲ 44×2 topics
- Glycosylation12▲ 25×3 topics
- ATM and ATR Kinases12▲ 109×1 topic
- Repair12▲ 109×1 topic
- Drug Discovery12▲ 13×7 topics
- DNA Repair10▲ 193×2 topics
- Synthetic Lethality10▲ 183×2 topics
- BRCA Mutation10▲ 267×1 topic
- PARP Inhibitors10▲ 267×1 topic
- Monoclonal Antibodies9▲ 30×2 topics
- Therapeutic Antibodies9▲ 33×2 topics
- Cell Signaling9▲ 13×6 topics
- Pharmacology9▲ 12×7 topics
- Crystal Structure9▲ 16×4 topics
- Molecular Mechanisms9▲ 22×3 topics
- Antibiotic Resistance9▲ 9.8×5 topics
- Arrestin8▲ 47×1 topic
- G-Protein-Coupled Receptors8▲ 47×1 topic
- Gene Regulation8▲ 25×3 topics
- Stress8▲ 8.9×4 topics
- Anxiety8▲ 9.7×2 topics
- Immune Modulation8▲ 25×3 topics
- Membrane Proteins8▲ 19×3 topics
- Neuropeptides8▲ 33×2 topics
- Depression8▲ 4.6×5 topics
- Antibody Engineering7▲ 33×1 topic
- Fc Receptors7▲ 33×1 topic
- Opioid7▲ 55×1 topic
- Receptors7▲ 55×1 topic
- RNA Regulation6▲ 26×2 topics
- Bacterial Physiology6▲ 58×1 topic
- Cellular Homeostasis6▲ 46×1 topic
- Genomics6▲ 7.7×8 topics
Which research topics does École Supérieure de Biotechnologie de Strasbourg publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Toxin Mechanisms and Immunotoxins, PARP inhibition in cancer therapy and Chemical Synthesis and Analysis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 2 Toxin Mechanisms and Immunotoxins Immunology 0 works
- 3 PARP inhibition in cancer therapy Oncology 0 works
- 4 Chemical Synthesis and Analysis Molecular Biology 0 works
- 5 Receptor Mechanisms and Signaling Molecular Biology 0 works
- 6 DNA Repair Mechanisms Molecular Biology 0 works
- 7 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
- 8 Bacterial biofilms and quorum sensing Molecular Biology 0 works
- 9 Protein purification and stability Molecular Biology 0 works
- 10 Immune Response and Inflammation Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has École Supérieure de Biotechnologie de Strasbourg's research output changed?
Output in 2018–2022 was 10% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Illkirch-Graffenstaden
- Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie
- Institut de génétique et de biologie moléculaire et cellulaire
- Laboratoire de Biophotonique et Pharmacologie
- Transgene (France)
- International Space University
- Laboratoire de Chémo-biologie synthétique et thérapeutique
- Laboratoire d'Innovation Thérapeutique
- Institut Clinique de la Souris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.